Vaccine maker Biological E buys Akorn India to boost manufacturing capacity

Vaccine maker Biological E buys Akorn India to boost manufacturing capacity

Photo: National Cancer Institute/Unsplash

Vaccine manufacturer Biological E. Ltd on Monday announced the acquisition of Akorn India Ltd, a subsidiary of US-based Akorn Inc, for an undisclosed fee, providing a boost to the Hyderabad-based company’s manufacturing capacity as it prepares to mass produce two vaccine candidates, including that of Johnson & Johnson.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter